P.124 EDG-5506 targets fast skeletal myosin and reduces muscle damage biomarkers in a phase 1 trial in Becker muscular dystrophy (BMD) J. Donovan, N. Kilburn, G. Gordon,B. Barthel,M. DuVall, A. Bronson,A. Russell, C. Sherman, M. EvanchikNeuromuscular Disorders(2022)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要